Brief: Eurocine Vaccines Q3 Operating Loss Narrows To SEK 3.1 Million
May 15 (Reuters) - Eurocine Vaccines AB EUCI.TE :
* Q3 2018/19 OPERATING LOSS SEK 3.1 MILLION VERSUS LOSS SEK
15.9
MILLION YEAR AGO
* Q3 2018/2019 RESULT FOR THE PERIOD LOSS SEK 3.3 MILLION
VERSUS
LOSS 15.9 MILLION YEAR AGO
Source text for Eikon: ID:nWkr5zSSxQ
Further company coverage: EUCI.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Nidhogg Resources Holding AB (publ)
See all newsBrief: Nidhogg Resources Holding Resolves On A Directed Set-Off Share Issue
Brief: Nidhogg Resources Holding AB Announces The Termination Of The Al Baraka Project In Egypt
Brief: Eurocine Vaccines Q4 EPS at SEK -0.111
Brief: Eurocine Vaccines Says Decides To Develop mRNA-Based Vaccine Candidate Against Chlamydia
Brief: Eurocine Vaccines Expands Its Portfolio With A Therapeutic Hsv-2 Vaccine Candidate